Serum prolactin and CA-125 levels as biomarkers of peritoneal endometriosis

Gynecologic and Obstetric Investigation

Volumn 78, Issue 1, 2014, Pages 45-52

  Bilibio, João P ^a   Souza, Carlos A B ^a   Rodini, Gustavo P ^a   Andreoli, Carolina G ^a   Genro, Vanesa K ^a   De Conto, Emily ^a   Cunha Filho, João S L ^a  

^a HOSPITAL DE CLÍNICAS DE PORTO ALEGRE   (Brazil)

Author keywords

CA 125; Endometriosis; Noninvasive diagnosis; Peritoneal endometriosis; Prolactin

Indexed keywords

CA 125 ANTIGEN; PROLACTIN; BIOLOGICAL MARKER;

ARTICLE; COHORT ANALYSIS; CONTROLLED STUDY; DIAGNOSTIC TEST ACCURACY STUDY; ENDOMETRIOSIS; FEMALE; FEMALE INFERTILITY; HUMAN; HUMAN TISSUE; MAJOR CLINICAL STUDY; MENSTRUAL CYCLE; PERITONEAL ENDOMETRIOSIS; PREDICTIVE VALUE; PRIORITY JOURNAL; PROLACTIN BLOOD LEVEL; PROSPECTIVE STUDY; PROTEIN BLOOD LEVEL; SENSITIVITY AND SPECIFICITY; SPONTANEOUS ABORTION; ADULT; BLOOD; PERITONEAL DISEASE; BLOOD SAMPLING; DIAGNOSTIC ACCURACY; PELVIC PAIN; REFERENCE VALUE;

ADULT; BIOLOGICAL MARKERS; CA-125 ANTIGEN; COHORT STUDIES; ENDOMETRIOSIS; FEMALE; HUMANS; PERITONEAL DISEASES; PROLACTIN; PROSPECTIVE STUDIES; SENSITIVITY AND SPECIFICITY;

EID: 84904395443     PISSN: 03787346     EISSN: 1423002X     Source Type: Journal    
DOI: 10.1159/000362272     Document Type: Article

References (46)

1. Kennedy S, Bergqvist A, Chapron C, D'Hooghe T, Dunselman G, Greb R, et al: ESHRE guideline for the diagnosis and treatment of endo-metriosis. Hum Reprod 2005; 20:2698-2704. (Pubitemid 41487622)
2. Hadfield R, Mardon H, Barlow D, Kennedy S: Delay in the diagnosis of endometriosis: a survey of women from the USA and the UK. Hum Reprod 1996; 11:878-880. (Pubitemid 26142192)
3. Arruda MS, Petta CA, Abrao MS, Benetti-Pinto CL: Time elapsed from onset of symptoms to diagnosis of endometriosis in a cohort study of Brazilian women. Hum Reprod 2003; 18:756-759. (Pubitemid 36426953)
4. Coccia ME, Rizzello F, Mariani G, Bulletti C, Palagiano A, Scarselli G: Impact of endome-triosis on in vitro fertilization and embryo transfer cycles in young women: a stage-dependent interference. Acta Obstet Gynecol Scand 2011; 90:1232-1238.
5. Setala M, Harkki P, Matomaki J, Makinen J, Kossi J: Sexual functioning, quality of life and pelvic pain 12 months after endometriosis surgery including vaginal resection. Acta Ob-stet Gynecol Scand 2012; 91:692-698.
6. Simoens S, Hummelshoj L, Dunselman G, Brandes I, Dirksen C, D'Hooghe T: Endome-triosis cost assessment (the EndoCost study): a cost-of-illness study protocol. Gynecol Ob-stet Invest 2011; 71:170-176.
7. May KE, Conduit-Hulbert SA, Villar J, Kirt-ley S, Kennedy SH, Becker CM: Peripheral biomarkers of endometriosis: a systematic review. Hum Reprod Update 2010; 16: 651-674.
8. Jee BC, Suh CS, Kim SH, Moon SY: Serum soluble CD163 and interleukin-6 levels in women with ovarian endometriomas. Gyne-col Obstet Invest 2008; 66:47-52. (Pubitemid 352009131)
9. De Sanctis P, Elmakky A, Farina A, Caramelli E, Seracchioli R, Mabrouk M, et al: Matrix me-talloproteinase-3 mRNA: a promising peripheral blood marker for diagnosis of endometrio-sis. Gynecol Obstet Invest 2011; 71: 118-123.
10. Kang S, Shi YY, Li Y, Wang N, Lu YC, Zhou RM, et al: Association between genetic variants of the VEGFR-2 gene and the risk of developing endometriosis in Northern Chinese Women. Gynecol Obstet Invest 2013; 76: 32-37.
11. Mol BW, Bayram N, Lijmer JG, Wiegerinck MA, Bongers MY, van der Veen F, et al: The performance of CA-125 measurement in the detection of endometriosis: a meta-analysis. Fertil Steril 1998; 70:1101-1108. (Pubitemid 28546238)
12. Cheng YM, Wang ST, Chou CY: Serum CA-125 in preoperative patients at high risk for endometriosis. Obstet Gynecol 2002; 99:375-380.
13. Gregoriou G, Bakas P, Vitoratos N, Papadias K, Goumas K, Chryssicopoulos A, et al: Evaluation of serum prolactin levels in patients with endometriosis and infertility. Gynecol Obstet Invest 1999; 48:48-51. (Pubitemid 29338839)
14. Cunha-Filho JS, Gross JL, Lemos NA, Bran-delli A, Castillos M, Passos EP: Hyperprolac-tinemia and luteal insufficiency in infertile patients with mild and minimal endometrio-sis. Horm Metab Res 2001; 33:216-220. (Pubitemid 32454514)
15. Acien P, Lloret M, Graells M: Prolactin and its response to the luteinizing hormone-releasing hormone thyrotropin-releasing hormone test in patients with endometriosis before, during, and after treatment with danazol. Fer-til Steril 1989; 51:774-780. (Pubitemid 19127847)
16. He YE: Prolactin secretion in patients with endometriosis and its relationship to luteal phase defect and infertility (in Chinese). Zhonghua Fu Chan Ke Za Zhi 1993; 28:14-17, 59.
17. Lima AP, Moura MD, Rosa e Silva AA: Pro-lactin and cortisol levels in women with endo-metriosis. Braz J Med Biol Res 2006; 39:1121-1127.
18. Wang H, Gorpudolo N, Behr B: The role of prolactin-and endometriosis-associated infertility. Obstet Gynecol Surv 2009; 64:542-547.
19. Muse K, Wilson EA, Jawad MJ: Prolactin hy-perstimulation in response to thyrotropin-re-leasing hormone in patients with endometri-osis. Fertil Steril 1982; 38:419-422. (Pubitemid 12034436)
20. Radwanska E, Henig I, Dmowski WP: Nocturnal prolactin levels in infertile women with endometriosis. J Reprod Med 1987; 32:605-608. (Pubitemid 17138524)
21. Brosens IA, Koninckx PR, Corveleyn PA: A study of plasma progesterone, oestradiol-17beta, prolactin and LH levels, and of the lu-teal phase appearance of the ovaries in patients with endometriosis and infertility. Br J Obstet Gynaecol 1978; 85:246-250. (Pubitemid 8375359)
22. Matorras R, Rodriguez F, Perez C, Pijoan JI, Neyro JL, Rodriguez-Escudero FJ: Infertile women with and without endometriosis: a case control study of luteal phase and other infertility conditions. Acta Obstet Gynecol Scand 1996; 75:826-831. (Pubitemid 26373608)
23. Arumugam K: Serum prolactin levels in infertile patients with endometriosis. Malays J Pathol 1991; 13:43-45.
24. Matalliotakis I, Panidis D, Vlassis G, Vavilis D, Neonaki M, Koumantakis E: PRL, TSH and their response to the TRH test in patients with endometriosis before, during, and after treatment with danazol. Gynecol Obstet Invest 1996; 42:183-186. (Pubitemid 26354086)
25. Reese J, Binart N, Brown N, Ma WG, Paria BC, Das SK, et al: Implantation and decidual-ization defects in prolactin receptor (PRLR)-deficient mice are mediated by ovarian but not uterine PRLR. Endocrinology 2000; 141: 1872-1881. (Pubitemid 32274417)
26. Novella-Maestre E, Carda C, Noguera I, Ruiz-Sauri A, Garcia-Velasco JA, Simon C, et al: Dopamine agonist administration causes a reduction in endometrial implants through modulation of angiogenesis in experimentally induced endometriosis. Hum Reprod 2009; 24:1025-1035
27. ASMR: Revised American Society for Reproductive Medicine classification of endometri-osis: 1996. Fertil Steril 1997; 67:817-821.
28. Vimercati A, Achilarre MT, Scardapane A, Lorusso F, Ceci O, Mangiatordi G, et al: Accuracy of transvaginal sonography and contrast-enhanced magnetic resonance-colonog-raphy for the presurgical staging of deep infiltrating endometriosis. Ultrasound Obstet Gynecol 2012; 40:592-603.
29. Saccardi C, Cosmi E, Borghero A, Tregnaghi A, Dessole S, Litta P: Comparison between transvaginal sonography, saline contrast so-novaginography and magnetic resonance imaging in the diagnosis of posterior deep infiltrating endometriosis. Ultrasound Obstet Gy-necol 2012; 40:464-469.
30. Hudelist G, Ballard K, English J, Wright J, Ba-nerjee S, Mastoroudes H, et al: Transvaginal sonography versus clinical examination in the preoperative diagnosis of deep infiltrating en-dometriosis. Ultrasound Obstet Gynecol 2011; 37:480-487.
31. Bazot M, Lafont C, Rouzier R, Roseau G, Thomassin-Naggara I, Darai E: Diagnostic accuracy of physical examination, transvagi-nal sonography, rectal endoscopic sonogra-phy, and magnetic resonance imaging to diagnose deep infiltrating endometriosis. Fertil Steril 2009; 92:1825-1833.
32. Goncalves MO, Podgaec S, Dias JA Jr, Gonzalez M, Abrao MS: Transvaginal ultrasonogra-phy with bowel preparation is able to predict the number of lesions and rectosigmoid layers affected in cases of deep endometriosis, defining surgical strategy. Hum Reprod 2010; 25: 665-671.
33. Dan H, Limin F: Laparoscopic ovarian cystec-tomy versus fenestration/coagulation or laser vaporization for the treatment of endometri-omas: a meta-analysis of randomized controlled trials. Gynecol Obstet Invest 2013; 76: 75-82.
34. Xavier P, Beires J, Belo L, Rebelo I, Martinez-de-Oliveira J, Lunet N, et al: Are we employing the most effective CA 125 and CA 19-9 cut-off values to detect endometriosis? Eur J Obstet Gynecol Reprod Biol 2005; 123: 254-255. (Pubitemid 41728375)
35. Kitawaki J, Ishihara H, Koshiba H, Kiyomizu M, Teramoto M, Kitaoka Y, et al: Usefulness and limits of CA-125 in diagnosis of endome-triosis without associated ovarian endometri-omas. Hum Reprod 2005; 20:1999-2003. (Pubitemid 40932390)
36. Hudelist G, English J, Thomas AE, Tinelli A, Singer CF, Keckstein J: Diagnostic accuracy of transvaginal ultrasound for non-invasive diagnosis of bowel endometriosis: systematic review and meta-analysis. Ultrasound Obstet Gynecol 2011; 37:257-263.
37. Bilibio JP, Matte U, de Conto E, Genro VK, Souza CA, Cunha-Filho JS: Dopamine receptor D2 genotype (3438) is associated with moderate/severe endometriosis in infertile women in Brazil. Fertil Steril 2013; 99:1340-1345.
38. Somigliana E, Vigano P, Tirelli AS, Felicetta I, Torresani E, Vignali M, et al: Use of the concomitant serum dosage of CA 125, CA 19-9 and interleukin-6 to detect the presence of en-dometriosis. Results from a series of reproductive age women undergoing laparoscopic surgery for benign gynaecological conditions. Hum Reprod 2004; 19:1871-1876. (Pubitemid 39144638)
39. Agic A, Djalali S, Wolfler MM, Halis G, Died-rich K, Hornung D: Combination of CCR1 mRNA, MCP1, and CA125 measurements in peripheral blood as a diagnostic test for endo-metriosis. Reprod Sci 2008; 15:906-911.
40. Seeber B, Sammel MD, Fan X, Gerton GL, Shaunik A, Chittams J, et al: Panel of markers can accurately predict endometriosis in a subset of patients. Fertil Steril 2008; 89:1073-1081. (Pubitemid 351671727)
41. Maiorana A, Cicerone C, Niceta M, Alio L: Evaluation of serum CA 125 levels in patients with pelvic pain related to endometriosis. Int J Biol Markers 2007; 22:200-202. (Pubitemid 350081629)
42. Martinez S, Garrido N, Coperias JL, Pardo F, Desco J, Garcia-Velasco JA, et al: Serum inter-leukin-6 levels are elevated in women with minimal-mild endometriosis. Hum Reprod 2007; 22:836-842.
43. Mihalyi A, Gevaert O, Kyama CM, Simsa P, Pochet N, De Smet F, et al: Non-invasive diagnosis of endometriosis based on a combined analysis of six plasma biomarkers. Hum Reprod 2010; 25:654-664.
44. Moore J, Copley S, Morris J, Lindsell D, Gold-ing S, Kennedy S: A systematic review of the accuracy of ultrasound in the diagnosis of en-dometriosis. Ultrasound Obstet Gynecol 2002; 20:630-634. (Pubitemid 36002627)
45. Dessole S, Farina M, Rubattu G, Cosmi E, Ambrosini G, Nardelli GB: Sonovaginogra-phy is a new technique for assessing rectovag-inal endometriosis. Fertil Steril 2003; 79: 1023-1027. (Pubitemid 36385031)
46. Bazot M, Thomassin I, Hourani R, Cortez A, Darai E: Diagnostic accuracy of transvaginal sonography for deep pelvic endometriosis. Ultrasound Obstet Gynecol 2004; 24:180-185. (Pubitemid 39061844)